Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 500% increase over the number of companies inspected in the previous quarter, when one company received one inspection.
Most of the companies inspected at the time were involved in the Biologics sector. Both the Drugs and Food and Cosmetics sectors sectors tied for second most common type.
There were four companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. Two should take voluntary action to correct their management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Embryo Donation International | Biologics | 08/14/2024 | No Action Indicated (NAI) |
Health Park Medical Center | Biologics | 07/16/2024 | No Action Indicated (NAI) |
Lee County VA Healthcare Center | Biologics | 07/17/2024 | No Action Indicated (NAI) |
Prestige Packaging | Drugs | 07/18/2024 | Voluntary Action Indicated (VAI) |
Specialists in Reproductive Medicine & Surgery, P. A. | Biologics | 08/14/2024 | Voluntary Action Indicated (VAI) |
The Fine Cheese Company, LLC | Food and Cosmetics | 09/26/2024 | No Action Indicated (NAI) |